ALT (STOCKS)
Altimmune, Inc. Common Stock
$3.230300
-0.009700 (-0.30%)
Prev close: $3.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jerome B. Durso
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $419.48M
- Employees
- 59
- P/E (TTM)
- -3.19
- P/B (TTM)
- 1.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $41.00K |
| Benefits Costs and Expenses | $88.82M |
| Costs And Expenses | $88.82M |
| Nonoperating Income/Loss | $5.72M |
| Operating Expenses | $94.53M |
| Research and Development | $66.43M |
| Other Operating Expenses | $28.10M |
| Operating Income/Loss | -$94.49M |
| Income/Loss From Continuing Operations After Tax | -$88.09M |
| Income/Loss From Continuing Operations Before Tax | -$88.77M |
| Income Tax Expense/Benefit | -$681.00K |
| Income Tax Expense/Benefit, Deferred | -$681.00K |
| Net Income/Loss | -$88.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$88.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$88.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.00 |
| Diluted Earnings Per Share | -$1.00 |
| Basic Average Shares | 88,104,132 |
| Diluted Average Shares | 88,104,132 |
| Assets | $279.93M |
| Current Assets | $278.19M |
| Noncurrent Assets | $1.74M |
| Fixed Assets | $312.00K |
| Other Non-current Assets | $1.43M |
| Liabilities | $55.04M |
| Current Liabilities | $15.00M |
| Accounts Payable | $2.72M |
| Wages | $4.68M |
| Other Current Liabilities | $7.60M |
| Noncurrent Liabilities | $40.04M |
| Long-term Debt | $34.29M |
| Other Non-current Liabilities | $5.75M |
| Equity | $224.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $224.89M |
| Liabilities And Equity | $279.93M |
| Net Cash Flow From Operating Activities | -$67.54M |
| Net Cash Flow From Operating Activities, Continuing | -$67.54M |
| Net Cash Flow From Investing Activities | -$132.47M |
| Net Cash Flow From Investing Activities, Continuing | -$132.47M |
| Net Cash Flow From Financing Activities | $206.84M |
| Net Cash Flow From Financing Activities, Continuing | $206.84M |
| Net Cash Flow | $6.83M |
| Net Cash Flow, Continuing | $6.83M |
| Comprehensive Income/Loss | -$88.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$88.05M |
| Other Comprehensive Income/Loss | $45.00K |